Patent Assignment
Reel/Frame 051106/0789
Termination of Patent and Trademark Security Agreement
Recorded: 2019-11-25
Pages: 5
Assignor
PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
Executed: 2019-11-25
Assignee
KADMON PHARMACEUTICALS, LLC
119 COMMONWEALTH DRIVE, WARRENDALE, PENNSYLVANIA, 15806
Covered Properties
(3)
Process for Producing Wet Ribavirin Pellets
Composition Containing Ribavirin and Use Thereof
Large Dose Ribavirin Formulations
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0620 →
Security Agreement
Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0514 →
Release of Security Interest
Aug 31, 2015
From: MACQUARIE US TRADING LLC
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 036461/0825 →
Security Interest
Aug 31, 2015
From: KADMON PHARMACEUTICALS, LLC
To: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
Reel/Frame 036460/0811 →
Security Interest
Sep 2, 2015
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 036478/0611 →
Change of Name
Feb 3, 2016
From: THREE RIVERS PHARMACEUTICALS, LLC
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 037690/0466 →
Assignment of Assignor's Interest
Jul 26, 2022
From: KADMON PHARMACEUTICALS, LLC
To: CHARTWELL PHARMACEUTICALS LLC
Reel/Frame 060622/0317 →